Sankyo is a Japanese pharmaceutical company that focuses on the development, manufacturing, marketing and sales of prescription drugs. They offer a wide range of products in various therapeutic areas such as cardiovascular, respiratory, infectious diseases, and much more.
Sankyo Co., Ltd. was founded in 1931 in Tokyo, Japan
In 2005, Sankyo merged with Daiichi Pharmaceutical Co., Ltd.
In 2011, the company name was changed to Daiichi Sankyo Co., Ltd.
Daiichi Sankyo operates globally across more than 20 countries
A Japanese company that focuses on research, development, manufacturing and marketing of pharmaceutical products.
A Japanese pharmaceutical company that specializes in the development of drugs for oncology, urology, transplantation and health management and others
Treatment for hypertension that blocks the constriction effects of angiotensin II.
Treatment for lowering cholesterol levels and improving glycemic control.
Treatment for hypertension that combines two antihypertensive agents - olmesartan and amlodipine.
Daiichi Sankyo is a Japanese pharmaceutical company that focuses on the development, manufacturing, marketing and sales of prescription drugs.
Sankyo offers a wide range of products in various therapeutic areas such as cardiovascular, respiratory, infectious diseases, and much more.
Benicar is a treatment for hypertension that blocks the constriction effects of angiotensin II.
Yes, Daiichi Sankyo operates globally across more than 20 countries.
The competitors of Sankyo include Takeda Pharmaceuticals and Astellas Pharma Inc., among others.
